Filing Impact
Filing Sentiment
Form Type
6-K
Organigram Global Inc
May 27, 2025
Organigram Global Announces CEO Succession Plan
223.82M
90.78M
32.26%
6.05%
4.02%
Drug Manufacturers - Specialty & Generic
Healthcare
Canada
Toronto